BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 19519203)

  • 1. Molecular characterization and classification of neuroblastoma.
    Oberthuer A; Theissen J; Westermann F; Hero B; Fischer M
    Future Oncol; 2009 Jun; 5(5):625-39. PubMed ID: 19519203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in treatment and risk stratification of neuroblastoma: impact on future clinical and basic research.
    Øra I; Eggert A
    Semin Cancer Biol; 2011 Oct; 21(4):217-28. PubMed ID: 21798350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification of neuroblastoma patients by published gene-expression markers reveals a low sensitivity for unfavorable courses of MYCN non-amplified disease.
    Oberthuer A; Warnat P; Kahlert Y; Westermann F; Spitz R; Brors B; Hero B; Eils R; Schwab M; Berthold F; Fischer M
    Cancer Lett; 2007 Jun; 250(2):250-67. PubMed ID: 17126996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics and genomics of neuroblastoma.
    Capasso M; Diskin SJ
    Cancer Treat Res; 2010; 155():65-84. PubMed ID: 20517688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the understanding of constitutional and somatic genomic alterations in neuroblastoma.
    Deyell RJ; Attiyeh EF
    Cancer Genet; 2011 Mar; 204(3):113-21. PubMed ID: 21504710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic stratification of neuroblastoma for treatment tailoring.
    Jeison M; Yaniv I; Ash S
    Future Oncol; 2011 Sep; 7(9):1087-99. PubMed ID: 21919696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reanalysis of neuroblastoma expression profiling data using improved methodology and extended follow-up increases validity of outcome prediction.
    Schramm A; Mierswa I; Kaderali L; Morik K; Eggert A; Schulte JH
    Cancer Lett; 2009 Sep; 282(1):55-62. PubMed ID: 19349112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive genomics linking between neural development and cancer: neuroblastoma as a model.
    Nakagawara A; Ohira M
    Cancer Lett; 2004 Feb; 204(2):213-24. PubMed ID: 15013220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-mining of neuroblastoma and neuroblast gene expression profiles reveals candidate therapeutic compounds.
    De Preter K; De Brouwer S; Van Maerken T; Pattyn F; Schramm A; Eggert A; Vandesompele J; Speleman F
    Clin Cancer Res; 2009 Jun; 15(11):3690-6. PubMed ID: 19435837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of diagnostic value of chosen markers of neural differentiation in neuroblastoma group of tumors and pPNETs.
    Sałacińska-Łoś E; Kobos J; Taran K
    Pol J Pathol; 2008; 59(4):195-9. PubMed ID: 19391485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroblastoma genetics and phenotype: a tale of heterogeneity.
    Speleman F; De Preter K; Vandesompele J
    Semin Cancer Biol; 2011 Oct; 21(4):238-44. PubMed ID: 21839839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome 3p microsatellite allelotyping in neuroblastoma: a report on the technical hurdles.
    Hoebeeck J; De Wilde B; Michels E; Combaret V; Yigit N; De Smet E; Van Roy N; Stanbridge E; Ru N; Laureys G; De Paepe A; Speleman F; Vandesompele J
    Cancer Invest; 2009 Oct; 27(8):857-68. PubMed ID: 19544108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global genomic and RNA profiles for novel risk stratification of neuroblastoma.
    Ohira M; Nakagawara A
    Cancer Sci; 2010 Nov; 101(11):2295-301. PubMed ID: 20731666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic approaches in neuroblastoma: a complementary clinical platform for the future.
    Kumar HR; Zhong X; Rescorla FJ; Hickey RJ; Malkas LH; Sandoval JA
    Expert Rev Proteomics; 2009 Aug; 6(4):387-94. PubMed ID: 19681674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted radioiodine therapy of neuroblastoma tumors following systemic nonviral delivery of the sodium iodide symporter gene.
    Klutz K; Russ V; Willhauck MJ; Wunderlich N; Zach C; Gildehaus FJ; Göke B; Wagner E; Ogris M; Spitzweg C
    Clin Cancer Res; 2009 Oct; 15(19):6079-86. PubMed ID: 19789324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling: decoding breast cancer.
    de Snoo F; Bender R; Glas A; Rutgers E
    Surg Oncol; 2009 Dec; 18(4):366-78. PubMed ID: 19879448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Found in transcription: gene expression and other novel blood biomarkers for the early detection of breast cancer.
    Lönneborg A; Aarøe J; Dumeaux V; Børresen-Dale AL
    Expert Rev Anticancer Ther; 2009 Aug; 9(8):1115-23. PubMed ID: 19671031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New molecular classifications of breast cancer.
    Cianfrocca M; Gradishar W
    CA Cancer J Clin; 2009; 59(5):303-13. PubMed ID: 19729680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of molecular studies in the classification of lymphoma.
    Bagg A
    Expert Rev Mol Diagn; 2004 Jan; 4(1):83-97. PubMed ID: 14711352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.